Drug maker Alembic Pharma on Monday reported Rs 180 crore net profit in Q3FY24, which is a 48% year-on-year (YoY) increase compared to the corresponding period of the previous year led by India and US sales growth.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
